Global Human Milk Oligosaccharides (HMO) Market Report, History and Forecast 2017-2028
Market Analysis and Insights: Global Human Milk Oligosaccharides (HMO) Market
In 2021, the Global Human Milk Oligosaccharides (HMO) market size was valued at USD 378.52 Million, increased from USD 83.73 Million in 2017, and the market is forecasted to reach USD 1055.83 Million by 2028, growing at CAGR of 14.54% between 2022 and 2028.
The global main manufacturers of Human Milk Oligosaccharides (HMO) include Abbott, Inbiose, Glycom, Chr. Hansen (Jennewein), ZuChem, etc. In 2021, the global top 3 largest players have a share approximately 80.96% in terms of revenue.
Global Human Milk Oligosaccharides (HMO) Scope and Market Size
The global Human Milk Oligosaccharides (HMO) market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Human Milk Oligosaccharides (HMO) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type, and by Application for the period 2017-2028.
By Company
Abbott
Inbiose
Glycom
Chr. Hansen (Jennewein)
Elicityl SA
ZuChem
Segment by Type
2'-FL & 3-FL
Sialyllactose, LNT & LNnT, etc.
Segment by Application
Infant Formula
Functional Food & Beverages
Food/Medical Supplements, etc.
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Australia
Rest of APAC
Europe
Germany
UK
France
Belgium
Denmark
Rest of Europe
Latin America
Middle East & Africa
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook